Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-22-015738
Filing Date
2022-08-09
Accepted
2022-08-09 07:01:25
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K frln-20220630.htm   iXBRL 6-K 1844587
2 EX-99.1 frln-ex99_1.htm EX-99.1 153104
3 GRAPHIC img173576535_0.jpg GRAPHIC 2132
  Complete submission text file 0000950170-22-015738.txt   7019766

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frln-20220630.xsd EX-101.SCH 50760
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT frln-20220630_cal.xml EX-101.CAL 49729
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frln-20220630_lab.xml EX-101.LAB 376838
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT frln-20220630_def.xml EX-101.DEF 160173
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frln-20220630_pre.xml EX-101.PRE 290298
63 EXTRACTED XBRL INSTANCE DOCUMENT frln-20220630_htm.xml XML 1218436
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 221146328
SIC: 2836 Biological Products, (No Diagnostic Substances)